The medical letter on drugs and therapeutics/The medical letter
译名:药物与治疗学医学通讯
MEDICAL LETTER ON DRUGS AND THERAPEUTICS
1-3
2026
影响因子区间
—
平台估算
0%
2025
中国作者发文占比
—
收费
期刊简介:The Medical Letter, Inc. is committed to providing objective, practical, and timely information on drugs and treatments of common diseases to help our readers make the best decisions for their patients—without the influence of the pharmaceutical industry.The Medical Letter On Drugs and Therapeutics is a biweekly publication that provides:Evidence-based, peer-reviewed evaluations of new FDA-approved drugs with conclusions reached by a consensus of expertsNew information on previously approved drugs including pivotal clinical trials, new indications, and safety warningsConsensus recommendations for the preferred and alternative treatments for common disordersComparative reviews of drugs for a given indication with particular attention to clinical efficacy, adverse effects, drug interactions, and cost.
【译文】《医学通讯》公司致力于提供客观、实用和及时的信息,关于药物和常见疾病的治疗,以帮助读者为他们的患者做出最佳决定——不受制药行业的影响。《医学通讯:药物与治疗》是一本双周刊出版物,提供以下内容:基于证据、同行评审的新FDA批准药物的评价,由专家共识得出结论;关于先前批准的药物的新信息,包括关键临床试验、新适应症和安全警告;对常见疾病的优选和替代治疗方案达成共识的建议;针对特定适应症的药物比较综述,特别关注临床疗效、不良反应、药物相互作用和成本。
| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q4 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |